Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today)

Galileo Gets $31M To Advance Internal, Partnered Programs

May 2, 2003

By Aaron Lorenzo

No Comments

Rib-X Raises $51M To Push Ribosome-Based Antibiotics

May 2, 2003

By Aaron Lorenzo

No Comments

Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today)

Galileo Gets $31M To Advance Internal, Partnered Programs

May 2, 2003

By Aaron Lorenzo

No Comments

Cytokinetics Raises $40M To Move Pipeline Products Along

April 29, 2003

By Aaron Lorenzo

No Comments

Cytokinetics Raises $40M To Move Pipeline Products Along

April 29, 2003

By Aaron Lorenzo

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Aaron Lorenzo

Employees Return To Genelabs As $8.1 Million Placement Closes

AVI Raises $15M Privately From Investors Who Acted In A Hurry

RNA Tools Company Ambion Gets $10.5 Million In Private Placement

RNA Tools Company Ambion Gets $10.5 Million In Private Placement

Rib-X Raises $51M To Push Ribosome-Based Antibiotics

Galileo Gets $31M To Advance Internal, Partnered Programs

Rib-X Raises $51M To Push Ribosome-Based Antibiotics

Galileo Gets $31M To Advance Internal, Partnered Programs

Cytokinetics Raises $40M To Move Pipeline Products Along

Cytokinetics Raises $40M To Move Pipeline Products Along

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership